5 Einträge gefunden

1. Combination of a proteomics approach and reengineering of meso scale network models for prediction of mode-of-action for tyrosine kinase inhibitors

   1. Balabanov, Stefan
   2. Wilhelm, Thomas
   3. Venz, Simone
   4. Amsberg, Gunhild
   5. Scharf, Christian
   6. Pospisil, Heike
   7. Balabanov, Melanie

   2013 - Forschungsinformationssystem des UKE - frei zugänglich
2. Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.

   1. Preukschas, Michael
   2. Hagel, Christian
   3. Schulte, Alexander
   4. Riecken, Kristoffer
   5. Lamszus, Katrin
   6. Sievert, Henning
   7. Pällmann, Nora

   2012 - Forschungsinformationssystem des UKE - frei zugänglich
3. Abcg2 overexpression represents a novel mechanism for acquired resistance to the multi-kinase inhibitor Danusertib in BCR-ABL-positive cells in vitro.

   1. Balabanov, Stefan
   2. Gontarewicz, Artur
   3. von Amsberg, Gunhild
   4. Raddrizzani, Laura
   5. Balabanov, Melanie
   6. Bosotti, Roberta
   7. Moll, Jürgen

   2011 - Forschungsinformationssystem des UKE - frei zugänglich
4. Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells.

   1. Brassat, Ute
   2. Balabanov, Stefan
   3. Bali, Daniel
   4. Dierlamm, Judith
   5. Balabanov, Melanie
   6. Hartmann, Ulrike
   7. Sirma, Hüseyin

   2011 - Forschungsinformationssystem des UKE
5. Aurora kinase inhibitor PHA-739358 suppresses growth of hepatocellular carcinoma in vitro and in a xenograft mouse model.

   1. Benten, Daniel
   2. Keller, Gunhild
   3. Quaas, Alexander
   4. Schrader, Jörg
   5. Gontarewicz, Artur
   6. Balabanov, Stefan
   7. Balabanov, Melanie

   2009 - Forschungsinformationssystem des UKE - frei zugänglich